Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,325.40
-21.20 (-1.57%)
At close: Mar 27, 2026
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 221.48 billion as of March 27, 2026. Its market cap has increased by 5.54% in one year.
Market Cap
221.48B
Enterprise Value
210.37B
Revenue
26.63B
Ranking
n/a
PE Ratio
41.91
Stock Price
1,325.40
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 221.48B, an increase of 224.84%. That is a compound annual growth rate of 12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 221.48B | -10.60% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.59T |
| Apollo Hospitals Enterprise | 1.09T |
| Cipla | 1.00T |
| Krishna Institute of Medical Sciences | 254.65B |
| Inventurus Knowledge Solutions | 232.50B |
| Pfizer | 214.65B |
| Sai Life Sciences | 208.78B |